According to BB Biotech 's latest financial reports and stock price the company's current Operating Margin is -102.94%. At the end of 2022 the company had an Operating Margin of -101.86%.
Year | Operating Margin | Change |
---|---|---|
2022 | -101.86% | -0.29% |
2021 | -102.15% | -203.33% |
2020 | 98.86% | -0.01% |
2019 | 98.87% | -197.71% |
2018 | -101.18% | -201.99% |
2017 | 99.21% | -198.52% |
2016 | -100.70% | -201.67% |
2015 | 99.04% | -0.54% |
2014 | 99.58% | 0.21% |
2013 | 99.37% | 1.71% |
2012 | 97.69% | -101.91% |
2011 | -5,126.16% | -44.71% |
2010 | -9,270.85% | -13546.84% |
2009 | 68.94% | 12.06% |
2008 | 61.52% | |
2006 | 93.54% | -2.21% |
2005 | 95.65% | 0.74% |
2004 | 94.94% | 2.35% |
2003 | 92.76% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.